Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer

D. Skarlos, E. Samantas, P. Kosmidis, +12

Annals of Oncology

Radiation MedicineHealth SciencesRadiation TherapyMedicineCancer Treatment +6

Combination of Bisphosphonates and Antiangiogenic Factors Induces Osteonecrosis of the Jaw More Frequently than Bisphosphonates Alone

C. Christodoulou, A. Pervena, G. Klouvas, +9

Oncology

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

Christos Christodoulou, Dimitrios Bafaloukos, Helena Linardou, +5

Journal of Neuro-Oncology

Neuro-oncologyBrain MetastasesSolid TumorsMedicineMetronomic Therapy +6

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study

Evangelos Briasoulis, Gerasimos Aravantinos, George Kouvatseas, +12

BMC Cancer

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

Dimitrios Pectasides, George Papaxoinis, Konstantine T. Kalogeras, +17

BMC Cancer

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study

Christos Papadimitriou, Pavlos Papakostas, Maria Karina, +23

BMC Medicine

Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.

Davide Mauri, George Pentheroudakis, D. Bafaloukos, +10

PubMed

Advanced Lung DiseaseCancer ManagementRetrospective AnalysisPathologyOncology +14

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

Alexandra Stavropoulou, Florentia Fostira, Maroulio Pertesi, +17

PLoS ONE

Brca1 MutationsSomatic VariantCancer PathologyCancer RiskGenetic Disorder +12

Cavitating squamous cell lung carcinoma-distinct entity or not?

G. Pentheroudakis, L. Kostadima, George Fountzilas, +3

Lung Cancer

MedicinePathologySquamous CellPulmonary BlastomaOncology +3

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

George Fountzilas, Urania Dafni, Mattheos Bobos, +21

BMC Cancer